OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
2
Results
Show all
Save search
Copy query
Show results for
Unknown
(1)
Proteomics
(1)
Organisms
Chlamydia trachomatis E/C599
(1)
Spongospora sp.
(1)
Musa acuminata x Musa textilis
(1)
Centruroides hentzi
(1)
Pyrodictium delaneyi
(1)
Macrophomina phaseolina MS6
(1)
Escherichia coli O107
(1)
Campylobacter jejuni subsp. jejuni
(1)
Lactococcus cremoris
(1)
Sulfitobacter indolifex
(1)
Daucus carota subsp. sativus
(1)
Marivirga tractuosa
(1)
Microcebus murinus
(1)
unclassified Chromatiaceae
(1)
Plethodon shermani
(1)
Desmognathus ocoee
(1)
Chloris chloris chloris
(1)
Monascus purpureus
(1)
Cinclus cinclus
(1)
JC polyomavirus
(1)
Phylloscopus collybita
(1)
NEWT:5145
(1)
Acrocephalus palustris
(1)
Prunus dulcis
(1)
Mizuhopecten yessoensis
(1)
Squalus acanthias
(1)
Babesia canis
(1)
wood decay metagenome
(1)
Monilinia laxa
(1)
Hypotermes
(1)
Repository
pride
(1)
Tissue
Cell culture
(1)
Epithelial cell
(1)
Technology Type
Affinity purification coupled with mass spectrometry proteomics
(1)
Mass Spectrometry
(1)
Publication Date
2020
(1)
Release Date
2015
(1)
Lab affiliation
Institute of Biophysics, Chinese Academy of Sciences
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
identify H2AK119ub1 specific interactors using SILAC-MS methods
in this study, we performed the SILAC-MS to identify H2AK119ub1 specific binding proteins.Samples were analyzed on a Q Exactive equipped with an Easy n-LC 1000 HPLC system (Thermo Scientific)
ORGANISM(S):
Homo sapiens (Human)
2020-02-06
|
PXD017105
|
Pride
Silac-ms
H2a ubiqutination
Prorein interaction
Human
Cite
Molecular Mechanisms of Lipoic Acid Protection against Aflatoxin B₁-Induced Liver Oxidative Damage and Inflammatory Responses in Broilers.
Not available
S-EPMC4690129
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
